This report from a workshop on “Promoting R&D in Preventive Health Technologies,” held in India in December 2004 outlines the potential role that the biotechnology sector in India could have in HIV vaccine research and development. India, as other “innovative developing countries” such as Brazil and China, has the research and manufacturing capacity to take a significant role in HIV vaccine research and development. The report strongly advocate’s IAVI’s strategy of promoting public-private partnerships in order to finance such developments.

Go to key document